{"id":351177,"date":"2019-04-04T09:45:02","date_gmt":"2019-04-04T09:45:02","guid":{"rendered":"http:\/\/www.abnewswire.com\/pressreleases\/?p=351177"},"modified":"2019-04-04T09:45:02","modified_gmt":"2019-04-04T09:45:02","slug":"cancer-testing-and-cancer-screening-market-driven-by-demand-for-early-diagnosis","status":"publish","type":"post","link":"https:\/\/www.abnewswire.com\/pressreleases\/cancer-testing-and-cancer-screening-market-driven-by-demand-for-early-diagnosis_351177.html","title":{"rendered":"Cancer Testing and Cancer Screening Market Driven by Demand for Early Diagnosis"},"content":{"rendered":"<div style=\" width:250px; padding:8px 10px 10px 10px; float:right;\"><a href=\"https:\/\/www.abnewswire.com\/pressreleases\/wp-content\/uploads\/2019\/04\/1554378027.jpeg\" style=\"border:none !important;\" target=\"_blank\" rel=\"nofollow\" ><img decoding=\"async\" class=\"alignnone size-medium wp-image-29\" title=\"image\" src=\"https:\/\/www.abnewswire.com\/pressreleases\/wp-content\/uploads\/2019\/04\/1554378027.jpeg\" alt=\"\" width=\"200\" style=\"padding:0px 0px 10px 10px; border:0 solid !important;\" \/><\/a><\/p>\n<div class=\"quotes\" style=\" font-weight:bold; font-style:italic;\">\n<div>&#8220;Cancer Testing and Cancer Screening Market&#8221;<\/div>\n<\/div>\n<\/div>\n<div style=\"font-style:italic; padding:8px 0px;\">the global cancer testing market coupled with cancer screening market was worth around $123 to $133 billion as of 2018, and the demand is projected to grow at a CAGR of around 4.5% to 5.5% during the forecast period 2019 to 2025. <\/div>\n<p style=\"text-align: justify;\"><strong>Cancer Testing and Cancer Screening Market: Demand Analysis and Growth Forecast<\/strong><\/p>\n<p style=\"text-align: justify;\">As cancer remains the leading cause of death worldwide, and rapid increase in overall cancer-related deaths among people are demanding for the early cancer detection methods in order to identify cancer in early stages. Cancer screening is one of the best methods in order to detect cancer in the earlier stage and lower the cancer cases and deaths of the people. Universal screening plays a key role to lower prevalence cancer in a cost-effective manner. The biological and epidemics, efficiency, and potential impact of screening are directly related to cancer prevalence, these factors will increase the demand in the cancer screening market.<\/p>\n<p style=\"text-align: justify;\">According to a recent business intelligence report by <strong>IndustryARC<\/strong>, the global <a rel=\"nofollow\" href=\"https:\/\/industryarc.com\/reports\/request-quote?id=15062\"><strong>cancer testing market<\/strong><\/a> coupled with cancer screening market was worth around $123 to $133 billion as of 2018, and the demand is projected to grow at a compound annual growth rate <strong>(CAGR) of around 4.5% to 5.5%<\/strong> during the forecast period 2019 to 2025. The report is titled, &ldquo;Cancer Testing\/Screening Market: By Cancer Type (Lung, Blood, Bone, Others); By Technique (Imaging, Endoscopy, Molecular &amp; Genomics Testing); By Stage (TNM, Prognostic Factors, Others); By Gender; By Geography &ndash; Forecast (2019-2025).&rdquo;<\/p>\n<p style=\"text-align: justify;\"><strong>View Full Table of Contents of Cancer Testing and Cancer Screening Market:<\/strong><\/p>\n<p style=\"text-align: justify;\"><a rel=\"nofollow\" href=\"https:\/\/industryarc.com\/Report\/15062\/cancer-testing-screening-market.html\">https:\/\/industryarc.com\/Report\/15062\/cancer-testing-screening-market.html<\/a><\/p>\n<p style=\"text-align: justify;\">Cancer screening tests are important to reduce disparities in cancer mortality and morbidity in public health. Several deaths are caused mainly by breast, lung, and cervical cancers in order to reduce these deaths cancer screenings such as colorectal cancer screening, cervical cancer screening, and breast cancer screening are increasing in the market. The government initiatives towards cancer prevention and growing awareness among the people about health are driving the growth of the cancer screening market.<\/p>\n<p style=\"text-align: justify;\"><strong>Cancer Testing Market: Leading Segments<\/strong><\/p>\n<p style=\"text-align: justify;\">According to the American Cancer Society, the total number of new cancer cases and deaths in 2018 are assessed to be 1,735,350 cancer cases and 609,640 cancer deaths in the United States. Moreover, 14,070 ovarian cancer deaths were accounted in the U.S, this cancer accounts for 2.5% of the female cancer cases worldwide in 2018. Deaths by this cancer are more around 5% as it leads to low survival. In 2018 American Society of Clinical Oncology (ASCO) broadened its State of Cancer Care in America in order to provide multidisciplinary solutions to improve clinical trials in rural cancer care. Mainly Americans in rural areas cancers such as lung, cervical, colorectal, and prostate are higher in rates than urban areas. The increasing population of cancers in America made ASCO safeguard new therapies for every individual with cancer. The aforementioned cancer deaths and cases, as well as clinical trials for rural cancer care, will increase the demand for the cancer screening market in this region. Based on the geographical analysis, America held a major share of 50% to 55% in cancer testing market as of 2018. The American Cancer Society (ASC) recommends for cancer screening in order to detect cancer cases certain earlier. In 2018, breast cancer killed more than 40,000 Americans per year. This increase in such cancer population will demand more targeted therapies and cancer screening methods based on the recommended guidelines of age by ASC.<\/p>\n<p style=\"text-align: justify;\"><strong>Cancer Screening Market Trends<\/strong><\/p>\n<ul style=\"text-align: justify;\">\n<li>3D radiology services such as 3D breast tomosynthesis are the latest advancement in cancer screening technologies. This advancement will enable to capture images of the breast tissue in several layers, which will provide many opportunities to identify cancer tissue obscured by other tissue. This technology enables to detect 41% more invasive cancers.<\/li>\n<li>The new 3D imaging technology enables high-resolution 3D images in order to hasten screening and analysis, which is designed to identify cancer in early stages by fine calcifications and subtle lesions.<\/li>\n<li>OneTEST is the latest innovative method for the multi-cancer blood test, this test identifies cancer risk using tumor antigen markers. This test is available for many cancers such as lung, liver, colon, cervical, and prostate to picture their own cancer risks.<\/li>\n<\/ul>\n<p style=\"text-align: justify;\"><strong>Cancer Testing Market: Competitive Landscape<\/strong><\/p>\n<p style=\"text-align: justify;\">Some of the major players operating in cancer testing\/screening market are Dias Orin S.P.A, Epigenetics Ag, Techlab, Genextropy Inc.,&nbsp;M Genomics Ltd, 20\/20 GeneSystems, Inc., AB SCIEX, Abbott Laboratories, Abcodia Ltd., and Abingdon Health Ltd.<\/p>\n<p style=\"text-align: justify;\"><strong>Talk to one of our sales representative about the full report by providing your details in the link below:<\/strong><\/p>\n<p style=\"text-align: justify;\"><a rel=\"nofollow\" href=\"https:\/\/industryarc.com\/support.php?id=15062\">https:\/\/industryarc.com\/support.php?id=15062<\/a><\/p>\n<p style=\"text-align: justify;\">&nbsp;<\/p>\n<p style=\"text-align: justify;\"><strong>Related Reports<\/strong><\/p>\n<p style=\"text-align: justify;\"><strong>&nbsp;<\/strong><strong>A.&nbsp;&nbsp;&nbsp; <\/strong><strong>Cancer Biomarkers Market<\/strong><\/p>\n<p style=\"text-align: justify;\">https:\/\/industryarc.com\/Report\/15738\/cancer-biomarkers-market.html<\/p>\n<p style=\"text-align: justify;\">&nbsp;<strong>B.&nbsp;&nbsp;&nbsp;&nbsp; <\/strong><strong>Cancer Diagnostics Market<\/strong><\/p>\n<p style=\"text-align: justify;\">https:\/\/industryarc.com\/Report\/15739\/cancer-diagnostics-market.html<\/p>\n<p style=\"text-align: justify;\"><strong>&nbsp;<\/strong><\/p>\n<p style=\"text-align: justify;\"><strong>What can you expect from the report?<\/strong><\/p>\n<p style=\"text-align: justify;\">The Cancer Screening Market is Prepared with the Main Agenda to Cover the following 20 points:<\/p>\n<p style=\"text-align: justify;\">1. Cancer Screening Market Size by Product Categories &amp; Application&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<\/p>\n<p style=\"text-align: justify;\">2. Cancer Screening Market trends &amp; Relevant Market Data<\/p>\n<p style=\"text-align: justify;\">3. Manufacturer Landscape&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<\/p>\n<p style=\"text-align: justify;\">4. Distributor Landscape &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<\/p>\n<p style=\"text-align: justify;\">5. Pricing Analysis &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<\/p>\n<p style=\"text-align: justify;\">6. Top 10 End-user Analysis &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<\/p>\n<p style=\"text-align: justify;\">7. Product Benchmarking &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<\/p>\n<p style=\"text-align: justify;\">8. Product Developments &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<\/p>\n<p style=\"text-align: justify;\">9. Mergers &amp; Acquisition Analysis &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<\/p>\n<p style=\"text-align: justify;\">10. Patent Analysis<\/p>\n<p style=\"text-align: justify;\">11. Cancer Screening Market Demand Analysis (Revenue &amp; Volume)<\/p>\n<p style=\"text-align: justify;\">12. Country-level Analysis<\/p>\n<p style=\"text-align: justify;\">13. Competitor Analysis<\/p>\n<p style=\"text-align: justify;\">14. Cancer Screening Market Shares Analysis<\/p>\n<p style=\"text-align: justify;\">15. Value Chain Analysis<\/p>\n<p style=\"text-align: justify;\">16. Supply Chain Analysis<\/p>\n<p style=\"text-align: justify;\">17. Cancer Testing Market Strategic Analysis<\/p>\n<p style=\"text-align: justify;\">18. Cancer TestingMarket Current &amp; Future Market Landscape Analysis<\/p>\n<p style=\"text-align: justify;\">19. Opportunity Analysis<\/p>\n<p style=\"text-align: justify;\">20. Cancer Testing Market Revenue and Volume Analysis<\/p>\n<p style=\"text-align: justify;\"><strong>&nbsp;<\/strong><\/p>\n<p style=\"text-align: justify;\"><strong>Frequently Asked Questions:<\/strong><\/p>\n<p style=\"text-align: justify;\"><strong>Q. Does Industry ARC provide customized reports and charge additionally for limited customization?<\/strong><\/p>\n<p style=\"text-align: justify;\"><strong>Response<\/strong>: Yes, we can customize the report by extracting data from our database of reports and annual subscription databases. We can provide the following free customization:<\/p>\n<p style=\"text-align: justify;\">1. Increase the level of data in the application or end-user industry.<\/p>\n<p style=\"text-align: justify;\">2. Increase the number of countries in geography chapter.<\/p>\n<p style=\"text-align: justify;\">3. Find out market shares for other smaller companies or companies which are of interest to you.<\/p>\n<p style=\"text-align: justify;\">4. Company profiles can be requested based on your interest.<\/p>\n<p style=\"text-align: justify;\">5. Patent analysis, pricing, product analysis, product benchmarking, value and supply chain analysis can be requested for a country or end-use segment.<\/p>\n<p style=\"text-align: justify;\">Any other custom requirements can be discussed with our team, drop an e-mail to <a rel=\"nofollow\" href=\"mailto:sales@industryarc.com\">sales@industryarc.com<\/a>&nbsp; to discuss more about our consulting services.<\/p>\n<p style=\"text-align: justify;\"><strong>To request for a proposal, provide your details in the below link:<\/strong><\/p>\n<p style=\"text-align: justify;\"><a rel=\"nofollow\" href=\"https:\/\/industryarc.com\/subscription.php\">https:\/\/industryarc.com\/subscription.php<\/a><\/p>\n<p style=\"text-align: justify;\"><strong>About IndustryARC<\/strong>: IndustryARC is a Research and Consulting Firm that publishes more than 500 reports annually, in various industries such as Agriculture, Automotive, Automation &amp; Instrumentation, Chemicals and Materials, Energy and Power, Electronics, Food and Beverages, Information Technology, and Life sciences and Healthcare.<\/p>\n<p><span style='font-size:18px !important;'>Media Contact<\/span><br \/><strong>Company Name:<\/strong> <a href=\"https:\/\/www.abnewswire.com\/companyname\/industryarc.com_2200.html\" rel=\"nofollow\">IndustryARC<\/a><br \/><strong>Contact Person:<\/strong> Mr. Venkat Reddy<br \/><strong>Email:<\/strong> <a href=\"https:\/\/www.abnewswire.com\/email_contact_us.php?pr=cancer-testing-and-cancer-screening-market-driven-by-demand-for-early-diagnosis\" rel=\"nofollow\">Send Email<\/a><br \/><strong>Phone:<\/strong> 1-614-588-8538 (Ext: 101)<br \/><strong>Address:<\/strong>Madhapur  <br \/><strong>City:<\/strong> Hyderabad<br \/><strong>Country:<\/strong> India<br \/><strong>Website:<\/strong> <a href=\"http:\/\/industryarc.com\/\" target=\"_blank\" rel=\"nofollow\">http:\/\/industryarc.com\/<\/a><\/p>\n<p>&nbsp;<\/p>\n<p><img decoding=\"async\" src=\"https:\/\/www.abnewswire.com\/press_stat.php?pr=cancer-testing-and-cancer-screening-market-driven-by-demand-for-early-diagnosis\" alt=\"\" width=\"1px\" height=\"1px\" \/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>&#8220;Cancer Testing and Cancer Screening Market&#8221; the global cancer testing market coupled with cancer screening market was worth around $123 to $133 billion as of 2018, and the demand is projected to grow at a CAGR of around 4.5% to &hellip; <a href=\"https:\/\/www.abnewswire.com\/pressreleases\/cancer-testing-and-cancer-screening-market-driven-by-demand-for-early-diagnosis_351177.html\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[401],"tags":[],"class_list":["post-351177","post","type-post","status-publish","format-standard","hentry","category-Business"],"_links":{"self":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/351177","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/comments?post=351177"}],"version-history":[{"count":0,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/351177\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/media?parent=351177"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/categories?post=351177"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/tags?post=351177"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}